Connect with us

NEWS

Apolarion Takes Plasma Seed Treatment Into First Field Trials

Apolarion’s CHF 150,000 Venture Kick award funds first field trials of a plasma seed box for European seed houses replacing chemical coatings.

Published

on

Apolarion has obtained CHF 150,000 (€164,000) from Venture Kick to run the first field trials of its plasma seed-treatment device. The Lausanne spin-off from EPFL uses only air and electricity to knock pathogens off seeds, and the cheque is meant to put that box in front of paying seed houses.

The sum is the ceiling of a three-stage Swiss programme, not a venture round. The opening Apolarion wants is narrower than a global coatings market: high-value vegetable seed, above all organic lots, where chemical recipes are hardest to keep on the label.

CHF 150,000 Buys Apolarion Its First Field Season

On 3 November 2026 the EPFL spin-off said the Venture Kick money will pay for operational space, kit and staff so it can run its first series of field trials and put the device with customers. Luke Simons, co-founder and chief executive, called the programme the route into Switzerland’s startup network, and into training, coaching and advisers.

That CHF 150,000 is the programme total across three jury stages, which Venture Kick says can be reached within nine months. It is not a fourth cheque stacked on earlier kicks. A separate EPFL award came first.

THE MONEY BEHIND THE BOX

Backer Date announced Amount Job of the cash
EPFL Innogrant, sponsored by UBS 15 January 2026 CHF 100,000 Prototype, biological tests, first Swiss industrial pilot
Venture Kick Stage II 18 May 2026 CHF 40,000 Independent prototype, conferences, more letters of intent
Venture Kick programme total 3 November 2026 CHF 150,000 Field trials, sites, equipment and staff

The January Innogrant sits outside Venture Kick. EPFL said the team would use that CHF 100,000 Innogrant to build a prototype, finish biological validation and start a first pilot with Swiss industrial partners, working with Prof. Ivo Furno at the Swiss Plasma Center. Stage II in May paid for a unit that could leave the lab bench. The November total is the field season.

Stage 3 winners also get a shot at an extra CHF 850,000 from Kickfund. Apolarion’s own site still says the company is not currently raising. The new cash is for trials, not a priced round.

View this post on Instagram

Air and Electricity Replace the Coating Drum

Apolarion’s device is a modular cold atmospheric plasma unit. A strong electric field strips electrons from ordinary air, and the resulting mix of ions, free electrons and reactive particles hits the seed surface. The company says that mix inactivates harmful microbes while leaving the seed able to germinate, with no chemical coating and no heat step that would need a dryer.

EPFL described the same physics when it awarded the Innogrant: an electrically generated mix of reactive molecules from air that disinfects seeds at room temperature and pressure, offered as a cleaner stand-in for steam or pesticide treatments. The Bio-Plasma Laboratory at the Swiss Plasma Center already lists cold plasma seed surface decontamination among the uses it studies, along with germination and biofilm work, because the gas stays near room temperature while the electrons stay energetic.

THREE WAYS TO TREAT A SEED

  • Chemical coatings: Professional plants apply plant-protection products to the seed, and residues can follow the lot into soil; labels keep shrinking as active substances lose outdoor uses.
  • Heat and steam: The method avoids pesticides but draws a lot of energy and can cut seed vigour, which is a poor trade on expensive vegetable lots.
  • Cold plasma: Air plus electricity, no drying step, adjustable temperature, and a claim of organic compatibility because nothing is added to the seed.

Seed scientists have been running versions of that third method for years. Direct plasma roughens the seed coat, lifts water uptake and can cut fungal load; indirect work uses plasma-treated water. The physics is not new. The product question is whether a seed plant can run it on a clock, at a cost, without cooking the lot.

Why High-Value Vegetable Seed Comes First

When the founders entered Venture Kick they had a lab testing unit, Swiss Plasma Center backing and the Innogrant, and they had not yet met a customer. The jury process, they said on the Stage II note, pushed them off a broad seed-treatment map and onto high-value vegetable seed, especially for organic growers, “where regulatory pressure is highest and our solution has the clearest advantage.”

That is the wedge. A cereal plant can still shop among leftover chemistries and biologicals. An organic vegetable lot cannot take a residue, and heat is a blunt tool on thin, costly seed. Plasma that uses only air fits the claim they want to print on a bag.

The first real signal came when Swiss seed companies described pathogens affecting their business that existing treatments couldn’t handle, but that we had already successfully inactivated in the lab.

Apolarion founders, Venture Kick Stage II note, 18 May 2026

Stage II cash was meant to turn that lab result into a minimum viable product, to work the conference circuit, and to lock more first letters of intent with seed companies. The November money is supposed to take those letters into dirt.

Seed Houses Write the Purchase Order

Farmers are not the buyer. Apolarion is selling to seed companies and, on the side, to research institutes. The site asks those firms for collaborative field trials and lists equipment makers and seed processors as partners for a pilot line. The November announcement puts the Swiss and EU seed-treatment market at about USD 250 million and says more than 450 companies in the EU alone could be in range. The company pitches a global seed-treatment market above $15 billion. Those figures are its own map, not a census.

THE WEDGE IN NUMBERS

  • Yield at risk: Apolarion says seed-borne diseases cause yield losses of up to 90% when a lot goes wrong.
  • Home market: Swiss and EU seed treatment, on the company’s telling, is worth about USD 250 million.
  • Customer set: More than 450 seed-treatment firms in the EU, with first outreach aimed at vegetable and organic houses.
  • Global frame: A seed-treatment market the company puts above $15 billion, used as an investor slide, not as next year’s revenue.

The board and advisory bench matches that B2B path. Frédéric Lauchenauer, a board member and former president of Business Angels Switzerland, is ex-Syngenta. Dr. Annette Büttner-Mainik, the seed-pathology adviser, previously ran the seed testing lab at Agroscope and worked at KWS. The people who used to sit with chemical coatings and official seed tests are now around a plasma box.

The Swiss Plasma Center Already Did the Biology

Apolarion is a Swiss Plasma Center spin-out, not a software wrapper on someone else’s reactor. Jesús Poley-Sanjuán, a plasma physicist, and Simons, also a physics PhD, built the company out of that lab. Furno, an adjunct professor at the center and an APS Fellow, is named as co-inventor. So is Dr. Fabio Avino, a scientist there and a former CERN hand.

The lab’s own account of the work is careful. Cold non-thermal plasmas sit far from equilibrium: electrons make reactive oxygen and nitrogen species, ultraviolet light, electric fields and charged particles, while the gas stays close to room temperature, which is why seeds survive the pass. Direct treatment puts the lot in the discharge. Indirect treatment loads a liquid first. Apolarion is selling the direct box.

Germination lift showed up in that same center’s seed work well before there was a company. The commercial claim is stricter. The device has to inactivate the pathogens a seed house actually has, at a speed a line can live with, without a drop in vigour that would show up in an ISTA test. That is still a field result, not a paper.

The Venture Kick program has been so important in our journey. It introduced us to the startup network in Switzerland and gave us access to world-class training, coaching and advisors; helping achieve the early successes of Apolarion.

Luke Simons, CEO and co-founder, Apolarion

A Seed Pathologist Starts in January

The hire on the site is the tell for what the CHF 150,000 is actually for. Apolarion wants a seed pathologist in Lausanne, full time, on a 12-month post from 1 January 2027, with applications closing on 30 November 2026. The job is to prove the kit on several seeds and crops, using ISTA seed-health methods, and to watch germination and vigour. Bacteria and viruses are listed as a plus. That is a field-and-lab post, not a pitch-deck post.

FROM LAB UNIT TO FIELD SEASON

  1. 15 January 2026: EPFL announces the UBS-sponsored Innogrant of CHF 100,000 for prototype work and a first Swiss industrial pilot with Furno’s group.
  2. 18 May 2026: Venture Kick Stage II awards CHF 40,000 to leave the lab testing unit, build an independent prototype and collect letters of intent.
  3. 3 November 2026: Venture Kick’s CHF 150,000 programme total is announced to fund the first field trials and customer deployments.
  4. 30 November 2026: Applications close for the Lausanne seed-pathologist post.
  5. 1 January 2027: The pathologist is due to start a 12-month stint proving the device on multiple crops.

Until those trials read out, the device is a well-backed prototype with letters of intent. The company is already asking seed firms and farmers to request a trial. That is the honest state of play on 3 November, not a launched product.

Europe Already Banned Outdoor Neonic Seed Coatings

Apolarion lists “regulatory tailwind: EU chemical phase-out” among its investor points. The tailwind that is already on the books is older than the company. After EFSA reviews, the Commission confined imidacloprid, clothianidin and thiamethoxam to permanent greenhouses; outdoor uses of three neonicotinoids are banned. Applicants then withdrew renewals, and the approvals expired on 31 January 2019, 30 April 2019 and 1 December 2020. Acetamiprid remains approved through 28 February 2033. Seed houses that once relied on those coatings have been shopping for substitutes for years.

That hole is why a plasma box has a customer at all. It is also why the story is still open. Biological coatings, leftover chemistries and physical methods are all bidding for the same lots. Apolarion’s bet is that an air-and-electricity pass can take the organic vegetable slice first, then sit on a seed-treatment line without a residue. The CHF 150,000 pays for the season that will show whether Swiss seed companies were right when they said the lab had killed pathogens their current recipes could not.

Harry is the editor of IAQABA, an independent publication he owns and runs. A decade in journalism, beginning as a reporter and now as the editor of his own titles, has left him with a clear test for what deserves a story: it has to change what a reader knows or decides, and it has to rest on something he can point to. That rules out recycled press releases, forecasts with no data behind them and rumours that no document supports. It leaves room for a great deal, and the site covers news, business, science and technology alongside sports, entertainment and lifestyle, with travel, auto and gaming given the same standard rather than lighter treatment. Sources are primary wherever possible: the regulator's filing, the company's own statement, the transcript, the dataset, or the product on Harry's desk. Figures are checked before they are published and rechecked if a reader questions them. Mistakes are corrected under a published policy. Readers across the world can reach him directly at support@iaqaba.com.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending